C
Cellectis
Developing allogeneic CAR-T cells
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
- OVOdyssée Venture
- HPHEC Paris
- BABankInvest
Eurazeo- APAndera Partners
- HCHEC Challenge+
- IPInstitut Pasteur
Source: Dealroom Talent Intelligence.
Alumni founders
Former Cellectis employees who went on to found companies, sorted by Dealroom signal score.
ARArzedaEst. 2008
Alexandre ZanghelliniUnited States
UBUmoja BiopharmaEst. 2019
Andy ScharenbergUnited States
Frédéric PâquesFrance
ERErVimmuneEst. 2019
Stéphane DepilFranceGlobal footprint
team presence
across markets
Patents
92 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cellectis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cellectis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.